These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18688028)

  • 41. Decorin is one of the proteoglycans expressed in Walker 256 rat mammary carcinoma.
    Oba-Shinjo SM; Berto AG; Passerotti CC; Barbosa CD; Sampaio LO
    Braz J Med Biol Res; 2003 Aug; 36(8):1079-89. PubMed ID: 12886463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation.
    Yao H; Veine DM; Fay KS; Staszewski ED; Zeng ZZ; Livant DL
    Breast Cancer Res Treat; 2011 Jan; 125(2):363-75. PubMed ID: 20300829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts.
    Kobayashi E; Sasamura H; Mifune M; Shimizu-Hirota R; Kuroda M; Hayashi M; Saruta T
    Kidney Int; 2003 Oct; 64(4):1179-88. PubMed ID: 12969135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin.
    Schaefer L; Tsalastra W; Babelova A; Baliova M; Minnerup J; Sorokin L; Gröne HJ; Reinhardt DP; Pfeilschifter J; Iozzo RV; Schaefer RM
    Am J Pathol; 2007 Jan; 170(1):301-15. PubMed ID: 17200203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapamycin together with herceptin significantly increased anti-tumor efficacy compared to either alone in ErbB2 over expressing breast cancer cells.
    Wang LH; Chan JL; Li W
    Int J Cancer; 2007 Jul; 121(1):157-64. PubMed ID: 17304506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
    Huang X; Gao L; Wang S; Lee CK; Ordentlich P; Liu B
    Cancer Res; 2009 Nov; 69(21):8403-11. PubMed ID: 19826038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.
    Berardi DE; Flumian C; Campodónico PB; Urtreger AJ; Diaz Bessone MI; Motter AN; Bal de Kier Joffé ED; Farias EF; Todaro LB
    Cell Oncol (Dordr); 2015 Aug; 38(4):289-305. PubMed ID: 26044847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-metastasis activity of black rice anthocyanins against breast cancer: analyses using an ErbB2 positive breast cancer cell line and tumoral xenograft model.
    Luo LP; Han B; Yu XP; Chen XY; Zhou J; Chen W; Zhu YF; Peng XL; Zou Q; Li SY
    Asian Pac J Cancer Prev; 2014; 15(15):6219-25. PubMed ID: 25124601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer.
    Wolfson E; Solomon S; Schmukler E; Goldshmit Y; Pinkas-Kramarski R
    Cell Death Dis; 2018 Jan; 9(2):47. PubMed ID: 29352243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance.
    Huang X; Wang S; Lee CK; Yang X; Liu B
    Cancer Lett; 2011 Aug; 307(1):72-79. PubMed ID: 21497990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pro-apoptotic effect of decorin on rat mesangial cells in vitro].
    Wu HJ; Liu Y; Xue AM; Liu Y; Wang SX; Chen Q; Guo MY; Zhang ZG
    Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):174-8. PubMed ID: 18788594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth.
    Hermanto U; Zong CS; Wang LH
    Oncogene; 2001 Nov; 20(51):7551-62. PubMed ID: 11709727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of a decorin-like moleculein human melanoma.
    Ladányi A; Gallai M; Paku S; Nagy JO; Dudás J; Tímár J; Kovalszky I
    Pathol Oncol Res; 2001; 7(4):260-6. PubMed ID: 11882905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
    Zhang YG; Du Q; Fang WG; Jin ML; Tian XX
    Int J Oncol; 2008 Sep; 33(3):595-602. PubMed ID: 18695891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
    Hoeflich KP; O'Brien C; Boyd Z; Cavet G; Guerrero S; Jung K; Januario T; Savage H; Punnoose E; Truong T; Zhou W; Berry L; Murray L; Amler L; Belvin M; Friedman LS; Lackner MR
    Clin Cancer Res; 2009 Jul; 15(14):4649-64. PubMed ID: 19567590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of extracellular signal-regulated protein kinase1,2 results in down-regulation of decorin expression in fibroblasts.
    Laine P; Reunanen N; Ravanti L; Foschi M; Santra M; Iozzo RV; Kähäri VM
    Biochem J; 2000 Jul; 349(Pt 1):19-25. PubMed ID: 10861206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Way TD; Kao MC; Lin JK
    J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240.
    Abdel-Wahab N; Wicks SJ; Mason RM; Chantry A
    Biochem J; 2002 Mar; 362(Pt 3):643-9. PubMed ID: 11879191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PKC 412 small-molecule tyrosine kinase inhibitor: single-compound therapy for pancreatic cancer.
    El Fitori J; Su Y; Büchler P; Ludwig R; Giese NA; Büchler MW; Quentmeier H; Hines OJ; Herr I; Friess H
    Cancer; 2007 Oct; 110(7):1457-68. PubMed ID: 17676584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.